Research In Brief
This article was originally published in The Gray Sheet
Executive Summary
FDA A-fib meeting: FDA will host a public "think tank" meeting on the development of an atrial fibrillation registry on April 27 and 28 at its White Oak, Md., headquarters, Cardiac Electrophysiology and Monitoring Devices Branch Medical Officer Randall Brockman announced at the Boston Symposium on Atrial Fibrillation Jan. 16. The meeting is cosponsored by the Duke Cardiac Safety Research Consortium. More information will be available soon at the consortium's website, 1www.cardiac-safety.org
You may also be interested in...
FDA, Cardiac Safety Research Consortium To Develop AF Ablation Registry
A consortium of academics, manufacturers and government agencies plans to launch a national atrial fibrillation ablation registry, based on input from a variety of stakeholders at a meeting April 27 and 28 at FDA's White Oak, Md., headquarters
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.